[1]
Schreiber, R., Crane, K. and Patel, J. 2017. Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s50. DOI:https://doi.org/10.25251/skin.1.supp.49.